Impact of C-reactive protein and pulse pressure evaluated at the start of peritoneal dialysis on cardiovascular events in the course of treatment with peritoneal dialysis

Peritoneal Dialysis International

Volumn 30, Issue 3, 2010, Pages 300-310

  Han, Seung Seok ^a   Ahn, Jeong Myung ^a   Chin, Ho Jun ^a,b   Chae, Dong Wan ^a,b   Oh, Kook Hwan ^a   Joo, Kwon Wook ^a,b   Kim, Yon Su ^a,b   Ahn, Curie ^a,b   Han, Jin Suk ^a,b   Kim, Suhnggwon ^a,b   Na, Ki Young ^a,b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Arterial stiffness; C reactive protein (crp); Cardiovascular event; Comorbidity; Inflammation; Korea; Pulse pressure

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEMBRANE TRANSPORT; MORTALITY; OUTCOME ASSESSMENT; PATIENT; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS PATIENT; PERITONEAL TRANSPORT; PREDICTION; PRIORITY JOURNAL; PULSE PRESSURE; REVIEW; TREATMENT DURATION; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 77957661977     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2009.00064     Document Type: Review

References (41)

1. Oreopoulos DG. A backward look at the first 20 years of CAPD. Perit Dial Int 1998; 18:360-2.
2. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20:2587-93.
3. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009; 20:155-63.
4. Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, et al. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1983; 2(8351):642-4.
5. Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, et al. Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int 2007; 27: 432-40.
6. Wang AY. Cardiovascular risk factors in peritoneal dialysis patients revisited. Perit Dial Int 2007; 27(Suppl 2): S223-7.
7. Han SH, Lee JE, Kim DK, Moon SJ, Kim HW, Chang JH, et al. Long-term clinical outcomes of peritoneal dialysis patients: single center experience from Korea. Perit Dial Int 2008; 28(Suppl 3):S21-6.
8. Collins AJ, Chen SC, Gilbertson DT, Foley RN. CKD surveillance using administrative data: impact on the health care system. Am J Kidney Dis 2009; 53(Suppl 3):S27-36.
9. Stel VS, Kramer A, Zoccali C, Jager KJ. The 2006 ERA-EDTA Registry annual report: a précis. J Nephrol 2009; 22:1-12.
10. ESRD Registry Committee, Korean Society of Nephrology. Current renal replacement therapy in Korea. Available from: http://www.ksn.or.kr/journal/2007/index.html
11. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-52.
12. Wong JS, Port FK, Hulbert-Shearon TE, Carroll CE, Wolfe RA, Agodoa LY, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999; 55: 2515-23.
13. Hemmelgarn BR, Chou S, Wiebe N, Culleton BF, Manns BJ, Klarenbach S, et al. Differences in use of peritoneal dialysis and survival among East Asian, Indo Asian, and white ESRD patients in Canada. Am J Kidney Dis 2006; 48: 964-71.
14. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317:1098.
15. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant 2002; 17:1085-92.
16. Mandolfo S, Zucchi A, Cavalieri D'Oro L, Corradi B, Imbasciati E. Protein nitrogen appearance in CAPD patients: what is the best formula? Nephrol Dial Transplant 1996; 11:1592-6.
17. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004; 17:1086-119.
18. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-8.
19. Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004; 15:2186-94.
20. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascularrisk. J Am Coll Cardiol 1995; 25:1056-62.
21. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, et al.; PEACE Investigators. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 2007; 115: 1528-36.
22. Kim SB, Min WK, Lee SK, Park JS, Hong CD, Yang WS. Persistent elevation of C-reactive protein and ischemic heart disease in patients with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2002; 39:342-6.
23. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
24. Covic A, Goldsmith DJ, Florea L, Gusbeth-Tatomir P, Covic M. The influence of dialytic modality on arterial stiffness, pulse wave reflections, and vasomotor function. Perit Dial Int 2004; 24:365-72.
25. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG. Serum albumin in patients on continuous ambulatory peritoneal dialysis-predictors and correlations with outcomes. J Am Soc Nephrol 1993; 3:1501-7.
26. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38:399-403.
27. Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, et al. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2001; 12:814-21.
28. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P, et al. Pulse pressure: a predictor of longterm cardiovascular mortality in a French male population. Hypertension 1997; 30:1410-15.
29. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354-60.
30. Liu JH, Chen CC, Wang SM, Chou CY, Liu YL, Kuo HL, et al. Association between pulse pressure and 30-month allcause mortality in peritoneal dialysis patients. Am J Hypertens 2008; 21:1318-23. doi: 10.1038/ajh.2008.286
31. Khattar RS, Acharya DU, Kinsey C, Senior R, Lahiri A. Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension. J Hypertens 1997; 15:737-43.
32. Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002; 39: 197-202.
33. Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 2003; 96:793-807.
34. Van Bortel LM, Struijker-Boudier HA, Safar ME. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001; 38:914-21.
35. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359:2195-207.
36. Karpanou EA, Vyssoulis GP, Stefanadis CI, Cokkinos DV. Differential pulse pressure response to various antihypertensive drug families. J Hum Hypertens 2006; 20:765-71.
37. Khan IH, Campbell MK, Cantarovich D, Catto GR, Delcroix C, Edward N, et al. Comparing outcomes in renal replacement therapy: how should we correct for case mix? Am J Kidney Dis 1998; 31:473-8.
38. Beddhu S, Zeidel ML, Saul M, Seddon P, Samore MH, Stoddard GJ, et al. The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. Am J Med 2002; 112:696-701.
39. Fried L, Bernardini J, Piraino B. Comparison of the Charlson Comorbidity Index and the Davies score as a predictor of outcomes in PD patients. Perit Dial Int 2003; 23: 568-73.
40. Toprak A, Reddy J, Chen W, Srinivasan S, Berenson G. Relation of pulse pressure and arterial stiffness to concentric left ventricular hypertrophy in young men (from the Bogalusa Heart Study). Am J Cardiol 2009; 103:978-84.
41. Han DS, Hwang JH, Kang DH, Song HY, Noh H, Shin SK, et al. Current status of peritoneal dialysis in Korea: efforts to achieve optimal outcome. Perit Dial Int 1999; 19(Suppl 3):S17-25.